Unraveling the Immune Signature of Herpes Zoster: Insights Into the Pathophysiology and Human Leukocyte Antigen Risk Profile
- PMID: 38195164
- PMCID: PMC11420803
- DOI: 10.1093/infdis/jiad609
Unraveling the Immune Signature of Herpes Zoster: Insights Into the Pathophysiology and Human Leukocyte Antigen Risk Profile
Abstract
The varicella-zoster virus (VZV) infects >95% of the population. VZV reactivation causes herpes zoster (HZ), known as shingles, primarily affecting the elderly and individuals who are immunocompromised. However, HZ can occur in otherwise healthy individuals. We analyzed the immune signature and risk profile in patients with HZ using a genome-wide association study across different UK Biobank HZ cohorts. Additionally, we conducted one of the largest HZ human leukocyte antigen association studies to date, coupled with transcriptomic analysis of pathways underlying HZ susceptibility. Our findings highlight the significance of the major histocompatibility complex locus for HZ development, identifying 5 protective and 4 risk human leukocyte antigen alleles. This demonstrates that HZ susceptibility is largely governed by variations in the major histocompatibility complex. Furthermore, functional analyses revealed the upregulation of type I interferon and adaptive immune responses. These findings provide fresh molecular insights into the pathophysiology and activation of innate and adaptive immune responses triggered by symptomatic VZV reactivation.
Keywords: HLA association; gene expression analysis; genome-wide association study; herpes zoster; type I interferon response.
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. J.-L. C. is an inventor on patent application PCT/US2021/042741 (filed 22 July 2021; submitted by The Rockefeller University), which covers diagnosis of susceptibility to, and treatment of, viral disease and viral vaccines, including COVID-19 and vaccine-associated diseases. B. O., K. L., and P. M. are employees and/or stockholders of Immunewatch, which is a spin-off company focusing on the development of artificial intelligence–based models that give insights into the T-cell response. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
References
-
- Bilcke J, Ogunjimi B, Marais C, et al. . The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect 2012; 140:2096–109. - PubMed
MeSH terms
Substances
Grants and funding
- Excellence Centre Infla-Med
- Chan Zuckerberg Initiative STEGO
- Meyer Foundation
- IOF POC 46947/Excellence Centre MST
- Grandir-Fonds de solidarité pour l'enfance
- ANR-21-RHUS-08/ANR-RHU COVIFERON Program
- ANR-22-CE15-0046/ANR AI2D
- 01057100/HORIZON-HLTH-2021-DISEASE-04 Program
- St Giles Foundation
- The Rockefeller University
- Bettencourt-Schueller Foundation
- ANR-10-LABX-62-IBEID/Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence
- INSERM;
- 1861219N/Research Foundation Flanders
- University of Paris
- Excellence Centre ASCID
- Poste CCA-INSERM-Bettencourt
- Battersea & Bowery Advisory Group
- R01AI163029/NH/NIH HHS/United States
- University of Antwerp Methusalem VAXINFECTIO
- ANR-10-IAHU-01/Agence Nationale de la Recherche
- EA20170638020/Fondation pour la Recherche Médicale
- HHMI/Howard Hughes Medical Institute/United States
- Square Foundation
- French Government
- ANR-20-CE93-003/ANR GENVIR
- REACTing-INSERM
- Fondation du Souffle
- SCOR Corporate Foundation for Science
- 851752-CELLULO-EPI/European Union's Horizon 2020 Research and Innovation Programme
- Flemish Interuniversity Council
- R01 AI163029/AI/NIAID NIH HHS/United States
- JPB Foundation
- MESRI-COVID-19/French Ministry of Higher Education, Research, and Innovation
- Hercules Foundation Flanders
- Fisher Center for Alzheimer's Research Foundation
LinkOut - more resources
Full Text Sources
Medical
Research Materials
